Related Experiment Videos
[Carbapenem resistance and Acinetobacter baumannii]
Enfermedades Infecciosas Y Microbiologia Clinica
|June 23, 2004
Summary
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Natural and synthetic chemicals acting as enhancers of bacterial pathogenic success within the human host.
Frontiers in cellular and infection microbiology·2026
Characterizing the V516M penicillin-binding protein 2 (PBP2) mutation causing zidebactam resistance in Pseudomonas aeruginosa.
Antimicrobial agents and chemotherapy·2026
Cefiderocol activity against multidrug-resistant isolates from the PERSEUS study: relationship between cefiderocol minimum inhibitory concentration and clinical outcomes.
The Journal of antimicrobial chemotherapy·2026
The role of whole genome sequencing in antimicrobial susceptibility prediction of bacteria: 2025 update from the European Committee on Antimicrobial Susceptibility Testing Subcommittee.
Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases·2026
New COVID-19 vaccination recommendations in Spain: Optimizing for next seasons.
Enfermedades infecciosas y microbiologia clinica·2025
Current situation in the development of a preventive HIV vaccine.
Enfermedades infecciosas y microbiologia clinica·2024
[Use of ribavirin in viruses other than hepatitis C. A review of the evidence].
Enfermedades infecciosas y microbiologia clinica·2024
[Respiratory viruses: old and new. Review of diagnostic methods].
Enfermedades infecciosas y microbiologia clinica·2024
Update on bacterial pathogens: virulence and resistance.
Enfermedades infecciosas y microbiologia clinica·2024
Lifting COVID-19 mitigation measures in Spain (May-June 2020).
Enfermedades infecciosas y microbiologia clinica·2023
Candida glabrata species complex in a Brazilian public tertiary hospital: site of infection, identification and antifungal susceptibility profile.
The journal of venomous animals and toxins including tropical diseases·2026
Bacterial EPIYA/EPIYA-like effector motifs and host regulatory pY-SH2 logic: a sequence-informed three-layer convergence model.
Frontiers in cellular and infection microbiology·2026
The PATHFAST TB LAM Ag assay: a validated protocol for quantitative tuberculosis treatment monitoring.
Frontiers in antibiotics·2026
Clinical utility of CSF metagenomic next-generation sequencing in suspected CNS infection: performance against a composite reference standard and read-count stratification.
Frontiers in cellular and infection microbiology·2026